Clinical trial
Effect of Age on Latanoprost 0.005% in Patients With Glaucoma
NCT00224289 · Yale University, Other · Completed
Key facts
| NCT number | NCT00224289 |
|---|---|
| Title | Effect of Age on Latanoprost 0.005% in Patients With Glaucoma |
| Official title | Effect of Age on Efficacy and Response Time of Latanoprost 0.005% in Patients With Glaucoma |
| Lead sponsor | Yale University, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Glaucoma |
| Intervention type | Drug |
| Interventions | Latanoprost 0.005% |
| Enrollment | 17 |
| Start date | Mar 1, 2005 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 10, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: